25.9 C
New York
Tuesday, June 9, 2026

Tag: growth factors

Online Gaming Market to Surge to USD 333.20 Billion by 2030, Driven by Technological Innovations and Cloud Integration: MarkNtel Advisors (Top Players – Tencent,...

NEW DELHI, July 30, 2025 /PRNewswire/ -- According to the latest industry analysis, the Global Online Gaming Market is projected to grow from USD 208.58...

Fruit and Vegetables Market Size Projected to Surpass USD 388.37 Billion by 2034, Backed by Organic and Fresh Produce Demand

According to Towards FnB, the global fruit and vegetables market size is evaluated at USD 244 billion in 2025 and is forecasted to hit around USD 388.37 billion by 2034, growing at a CAGR of 5.3% during the forecast period from 2025 to 2034.
According to Towards FnB, the global fruit and vegetables market size is evaluated at USD 244 billion in 2025 and is forecasted to hit around USD 388.37 billion by 2034, growing at a CAGR of 5.3% during the forecast period from 2025 to 2034.

Dover Reports Second Quarter 2025 Results

DOWNERS GROVE, Ill., July 24, 2025 /PRNewswire/ -- Dover (NYSE: DOV), a diversified global manufacturer, announced its financial results for the second quarter ended...

Smart Factory Market worth $169.73 billion by 2030 – Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., July 18, 2025 /PRNewswire/ -- The global smart factory market is projected to reach USD 104.42 billion in 2025 and USD 169.73...

Smart Factory Market worth $169.73 billion by 2030 – Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., July 18, 2025 /PRNewswire/ -- The global smart factory market is projected to reach USD 104.42 billion in 2025 and USD 169.73...

Henry Ford Health Initiates Patient Enrollment for BioCardia’s CardiAMP HF II Pivotal Study for Ischemic Heart Failure of Reduced Ejection Fraction

SUNNYVALE, Calif., July 16, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, announced today that Henry Ford Health in Detroit, Michigan is now enrolling patients with ischemic HFrEF in the Company’s ongoing pivotal CardiAMP HF II trial.

Longevity Health Holdings Announces Merger with THPlasma and Termination of 20/20 BioLabs Transaction

PITTSBURGH, July 14, 2025 (GLOBE NEWSWIRE) -- Longevity Health Holdings, Inc. (Nasdaq: XAGE), a company focused on human longevity and healthy aging (“Longevity”, the “Company”, “we”, “our”, or “us”), today announced the execution of a definitive merger agreement (the “Merger”) with True Health Inc., a leading player in the fast growing plasma collection industry under the THPlasma brand (“THPlasma”), to combine the companies in an all-stock transaction. Following the closing of the Merger (the “Closing”), the combined company is expected to continue to trade on Nasdaq under the symbol “XAGE.”

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsGrowth factors